PhaseBio Pharmaceuticals, Inc. (PHAS)
Operating Cash Flow (Statement)
-$59.42M
TTM · Period ending: · USD
PHAS Operating Cash Flow (Statement)
Latest reported-$59.42Mperiod ending
Latest reported-$59.42Mperiod ending
PHAS TTM Cash from Operations (-$11.15M → -$59.42M)
TTM operating cash flow (statement)
High-resolution chart · PNG
PHAS operating cash flow (statement) history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -59,421,000 | |
| -60,100,000 | |
| -47,416,000 | |
| -38,767,000 | |
| -48,462,000 | |
| -46,330,000 | |
| -59,957,000 | |
| -61,101,000 | |
| -53,514,000 | |
| -54,690,000 | |
| -39,594,000 | |
| -33,943,000 | |
| -29,279,000 | |
| -23,150,000 | |
| -17,053,000 | |
| -12,639,000 | |
| -11,153,000 |